Article
miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability
25 Oct 2019
Abstract excerpt
BACKGROUND: Gestational diabetes mellitus (GDM) leads to poor pregnancy outcomes. Strategies that improve trophoblast cell function are important methods for GDM treatment. This study aimed to investigate the expression and diagnostic potential of microRNA-132 (miR-132) in GDM patients, and further analyzed the effects of miR-132 on HTR-8/SVneo cell proliferation. METHODS: Quantitative real-time PCR was applied...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
